Meet The Team
 

Necdet Gunsoy, MPH PhD

​​

​

Necdet Gunsoy has over a decade of technical and leadership expertise in the pharmaceutical industry, specializing in health economics and outcomes research (HEOR), health technology assessment (HTA), indirect treatment comparisons (ITC), and real world evidence (RWE). He has a proven track record of developing reimbursement evidence and economic models for global markets, including key regions such as the UK, Germany, France, and Canada. Necdet's extensive leadership experience includes building and managing large technical teams, launch evidence strategy planning, preparation, and execution. His technical knowledge and strategic insights have made significant contributions to market access and pricing strategies in diverse therapeutic areas.

​​

Jiumei Gao 

​​

​

Jiumei brings over two years of healthcare consultancy experience, specializing in market access strategies and health economics across global markets. Her fluency in both Chinese and Japanese makes her perfectly positioned to navigate APAC marketplaces. Before entering consultancy, she worked in the non-profit sector, where she was committed to enhancing patient outcomes.

​

​

​

​

​

​

​

​

Chaitanyamayee Kalakota

​​

​

Chaitanyamayee brings a unique combination of expertise in pharmaceutical sciences and health economics. After completing her Bachelor’s in pharmaceutical science and a master's in pharmacy practice, she discovered her passion for health economics and went on to earn an MSc in Health Economics from the University of York. Her dissertation, “Producing robust estimates of cost-effectiveness in the presence of data gaps: assessment of NICE HST appraisals” explored the rare diseases where she conducted a targeted review of HST appraisals and developed an early cost-effectiveness model to address the uncertainty where data limitations are common.
 

​

​